Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models
Yoko Irukayama‐Tomobe, Yasuhiro Ogawa, Hiromu Tominaga, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 22, pp. 5731-5736
Open Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment
Claudio L. Bassetti, Antoine Adamantidis, Denis Burdakov, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 9, pp. 519-539
Closed Access | Times Cited: 492
The neurobiological basis of narcolepsy
Carrie E. Mahoney, Andrew C. Cogswell, Igor J. Koralnik, et al.
Nature reviews. Neuroscience (2018) Vol. 20, Iss. 2, pp. 83-93
Open Access | Times Cited: 216
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation
Chuan Hong, Noel Byrne, Beata Zamlynny, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 104
Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 71
Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1
Yves Dauvilliers, Emmanuel Mignot, Rafael del Río Villegas, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 4, pp. 309-321
Closed Access | Times Cited: 40
To eat or to sleep: That is a lateral hypothalamic question
Elda Arrigoni, Melissa J. Chee, Patrick M. Fuller
Neuropharmacology (2018) Vol. 154, pp. 34-49
Closed Access | Times Cited: 115
Hypocretin underlies the evolution of sleep loss in the Mexican cavefish
James B. Jaggard, Bethany A. Stahl, Evan Lloyd, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 111
The hypocretin (orexin) system: from a neural circuitry perspective
Shi‐Bin Li, Luı́s de Lecea
Neuropharmacology (2020) Vol. 167, pp. 107993-107993
Closed Access | Times Cited: 111
Recent advances in treatment for narcolepsy
Lucie Barateau, Yves Dauvilliers
Therapeutic Advances in Neurological Disorders (2019) Vol. 12
Open Access | Times Cited: 84
TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice
Hiroshi Yukitake, Tatsuhiko Fujimoto, Takashi Ishikawa, et al.
Pharmacology Biochemistry and Behavior (2019) Vol. 187, pp. 172794-172794
Closed Access | Times Cited: 83
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
The orexin story, sleep and sleep disturbances
Fabio Pizza, Lucie Barateau, Yves Dauvilliers, et al.
Journal of Sleep Research (2022) Vol. 31, Iss. 4
Closed Access | Times Cited: 48
Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy
Steven T. Szabo, Michael J. Thorpy, Geert Mayer, et al.
Sleep Medicine Reviews (2018) Vol. 43, pp. 23-36
Open Access | Times Cited: 72
Activation of orexin system facilitates anesthesia emergence and pain control
Wei Zhou, Kevin J. Cheung, Steven Kyu, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 45
Open Access | Times Cited: 66
Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications
Michael J. Thorpy, Richard Bogan
Sleep Medicine (2019) Vol. 68, pp. 97-109
Closed Access | Times Cited: 64
Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases
Alain Couvineau, Thierry Voisin, Pascal Nicole, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 63
Hypocretin/Orexin Receptor Pharmacology and Sleep Phases
Yu Sun, Ryan K. Tisdale, Thomas S. Kilduff
Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences (2021), pp. 22-37
Open Access | Times Cited: 42
Orexin 2 receptor‐selective agonist danavorexton ( TAK ‐925) promotes wakefulness in non‐human primates and healthy individuals
Rebecca Evans, Haruhide Kimura, Masato Nakashima, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 5
Open Access | Times Cited: 19
Orexin Signaling: A Complex, Multifaceted Process
Natasha C. Dale, Daniël Hoyer, Laura H. Jacobson, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 26
A photocaged orexin-B for spatiotemporally precise control of orexin signaling
Loïc Duffet, Petr V. Tatarskiy, Masaya Harada, et al.
Cell chemical biology (2022) Vol. 29, Iss. 12, pp. 1729-1738.e8
Open Access | Times Cited: 24
TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy
Takashi Ishikawa, Hiroe Hara, Ayumi Kawano, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 385, Iss. 3, pp. 193-204
Open Access | Times Cited: 15
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
Design and Synthesis of Orexin 1 Receptor-Selective Agonists
Keita Iio, Kao Hashimoto, Yasuyuki Nagumo, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 8, pp. 5453-5464
Open Access | Times Cited: 13
The present and future of synthetic orexin receptor agonists
Tsuyoshi Saitoh, Takeshi Sakurai
Peptides (2023) Vol. 167, pp. 171051-171051
Open Access | Times Cited: 13
Narcolepsy and rapid eye movement sleep
Francesco Biscarini, Lucie Barateau, Fabio Pizza, et al.
Journal of Sleep Research (2024)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top